SCHEDULE: FMR LLC, Abigail Johnson Boost Elanco Stake to 10.5%
Beneficial Ownership Disclosure
FMR LLC and Abigail P. Johnson have disclosed an increased beneficial ownership of 10.5% in Elanco Animal Health Inc., holding over 52 million common shares.
Summary
- FMR LLC and Abigail P. Johnson collectively beneficially own 52,196,321.38 shares of Elanco Animal Health Inc. common stock.
- This represents 10.5% of the total outstanding common stock of Elanco Animal Health Inc.
- FMR LLC holds sole voting power over 44,813,598.91 shares and sole dispositive power over 52,196,321.38 shares.
- Abigail P. Johnson holds sole dispositive power over 52,196,321.38 shares.
- The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Elanco Animal Health Inc.
- Several FMR LLC subsidiaries, including Fidelity Management & Research Company LLC, are identified as entities beneficially owning shares, with Fidelity Management & Research Company LLC owning 5% or greater.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, as a large, established institutional investor like FMR LLC maintaining a significant stake suggests confidence in Elanco's long-term prospects and stability.
Positives
- A significant institutional investor, FMR LLC, and its principal, Abigail P. Johnson, maintaining a substantial 10.5% stake in Elanco Animal Health Inc. indicates continued confidence in the company.
- The filing explicitly states the shares are held in the ordinary course of business and not for influencing control, suggesting a long-term investment perspective rather than activist intent.
Risks
- No specific risks related to Elanco Animal Health Inc.'s operations or financial health are disclosed in this ownership filing. The filing is solely about beneficial ownership.
Management Comments
- The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.
Industry Context
StockSavvy.ai notes that a significant stake held by a major institutional investor like FMR LLC in Elanco Animal Health Inc. underscores the attractiveness of the animal health sector, which often demonstrates resilience and steady growth driven by pet ownership trends and livestock management needs. This continued investment by a prominent asset manager suggests a positive long-term view on Elanco's position within this stable industry.
Comparison to Industry Standards
- This filing primarily concerns beneficial ownership disclosure and does not contain operational or financial performance data that would allow for direct comparison to specific comparable companies, projects, or results within the animal health industry. However, the 10.5% stake held by FMR LLC is a substantial institutional position, indicating a significant long-term commitment that aligns with typical large-cap institutional investment strategies.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Reporting Person Internal Governance Disclosure | The filing details that Abigail P. Johnson, as Director, Chairman, and CEO of FMR LLC, along with other Johnson family members, are the predominant owners of Series B voting common shares (representing 49% of the voting power) and have a shareholders' voting agreement. This arrangement means the Johnson family group may be deemed to form a controlling group with respect to FMR LLC under the Investment Company Act of 1940. | NA | This clarifies the internal control structure of FMR LLC, the reporting entity, and its subsidiaries. It does not directly indicate changes or impacts on Elanco Animal Health Inc.'s corporate governance, but rather the governance of the entity holding the shares. |
Stakeholder Impact
- Shareholders: The continued significant investment by FMR LLC may instill confidence among other shareholders, signaling institutional belief in Elanco's value.
- Management: A large, stable institutional shareholder can provide a degree of stability and oversight, potentially influencing long-term strategic decisions.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC. |
| 2023-01-10 | Date of Schedule 13G filing by FMR LLC (accession number -23-000003) where FMR LLC's Power of Attorney was incorporated by reference. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2023-01-31 | Date of Schedule 13G filing by FMR LLC (accession number -23-000038) where Abigail P. Johnson's Power of Attorney was incorporated by reference. |
| 2025-12-31 | Date of event which requires filing of this statement (measurement date for beneficial ownership). |
| 2026-02-04 | Date of filing of this Schedule 13G Amendment No. 3. |
Recommendation
holdThe filing indicates a stable, significant institutional holding by FMR LLC and Abigail P. Johnson in Elanco Animal Health Inc. This suggests continued confidence from a major investor, which is generally a positive signal. However, as a Schedule 13G filing, it primarily discloses ownership and does not provide new operational or financial performance data to warrant a 'buy' or 'sell' recommendation. The 'hold' recommendation reflects the stability implied by the institutional stake without new catalysts for significant price movement based solely on this disclosure.
Keywords
Elanco Animal Health Inc., ELANCO, FMR LLC, Abigail P. Johnson, Schedule 13G, beneficial ownership, institutional investment, common stock, animal health, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.